Literature DB >> 22131103

Scleroderma mimics.

Jennifer Nashel1, Virginia Steen.   

Abstract

Scleroderma is a rare systemic autoimmune disease with multiple organ manifestations, including skin fibrosis. The groups of disorders classified as scleroderma mimics share the common thread of skin thickening but are otherwise quite incongruous in terms of underlying disease process and other organ involvement. This article reviews the clinical presentation, etiology, and treatment options available for scleroderma mimics, including morphea, scleredema, diabetic cheiroarthropathy, scleromyxedema, nephrogenic systemic fibrosis, and eosinophilic fasciitis. Through greater understanding of these diseases and the associated extradermal implications, we hope to facilitate recognition of scleroderma and its mimics.

Entities:  

Mesh:

Year:  2012        PMID: 22131103     DOI: 10.1007/s11926-011-0220-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  37 in total

1.  Treatment of scleredema diabeticorum with tamoxifen.

Authors:  Sabri H Alsaeedi; Peter Lee
Journal:  J Rheumatol       Date:  2010-12       Impact factor: 4.666

Review 2.  Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature.

Authors:  Madison C Cuffy; Mansher Singh; Richard Formica; Evans Simmons; Ali K Abu Alfa; Kacie Carlson; Michael Girardi; Shawn E Cowper; Sanjay Kulkarni
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

3.  Diffuse fasciitis with eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  Trans Assoc Am Physicians       Date:  1975

4.  MRI for diagnosis and monitoring of patients with eosinophilic fasciitis.

Authors:  Franz Baumann; Pius Brühlmann; Gustav Andreisek; Beat A Michel; Borut Marincek; Dominik Weishaupt
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

5.  Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis.

Authors:  Alexander Kreuter; Thilo Gambichler; Stefan M Weiner; Gisela Schieren
Journal:  Arch Dermatol       Date:  2008-11

6.  Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.

Authors:  F Zulian; B H Athreya; R Laxer; A M Nelson; S K Feitosa de Oliveira; M G Punaro; R Cuttica; G C Higgins; L W A Van Suijlekom-Smit; T L Moore; C Lindsley; J Garcia-Consuegra; M O Esteves Hilário; L Lepore; C A Silva; C Machado; S M Garay; Y Uziel; G Martini; I Foeldvari; A Peserico; P Woo; J Harper
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

Review 7.  Scleredema adultorum of Buschke: a case report and review of the literature.

Authors:  William H Beers; Akgun Ince; Terry L Moore
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

8.  Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy.

Authors:  Narumol Thumpimukvatana; Chanisada Wongpraparut; Henry W Lim
Journal:  J Dermatol       Date:  2010-09-20       Impact factor: 4.005

9.  Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.

Authors:  Alexander Kreuter; Julia Hyun; Marina Skrygan; Anna Sommer; Nordwig S Tomi; Frank Breuckmann; Peter Altmeyer; Thilo Gambichler
Journal:  Arch Dermatol Res       Date:  2006-09-19       Impact factor: 3.017

Review 10.  Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.

Authors:  Gisela Schieren; Nikolaus Wirtz; Peter Altmeyer; Lars Christian Rump; Stefan Markus Weiner; Alexander Kreuter
Journal:  J Am Acad Dermatol       Date:  2009-11       Impact factor: 11.527

View more
  13 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

2.  Scleroderma Mimickers.

Authors:  Nadia D Morgan; Laura K Hummers
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-02-05

3.  An overlooked rheumatologic manifestation of diabetes: diabetic cheiroarthropathy.

Authors:  Neslihan Gokcen; Seher Cetinkaya Altuntas; Ilke Coskun Benlidayi; Murat Sert; Ersin Nazlican; Tunay Sarpel
Journal:  Clin Rheumatol       Date:  2019-02-02       Impact factor: 2.980

Review 4.  [Scleromyxedema].

Authors:  M Neufeld; C Sunderkötter; R K C Moritz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

5.  Therapy resistant idiopathic scleredema: an underlying pathology not always present.

Authors:  Melike Kalfa; Hayriye Koçanaoğulları; Figen Yargucu Zihni; Gonca Karabulut; Hakan Emmungil; Vedat İnal
Journal:  Eur J Rheumatol       Date:  2015-05-20

Review 6.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

7.  Scleredema developing after SARS-CoV-2 infection: a possible novel skin manifestation of coronavirus disease.

Authors:  Manuel Sánchez-Díaz; Ruben Lobato-Cano; Luis Salvador-Rodríguez; David Lopez-Delgado; Beatriz Espadafor-Lopez; Francisco Vilchez-Marquez; Francisco Ramos-Pleguezuelos; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  Eur J Dermatol       Date:  2022-02-01       Impact factor: 2.805

Review 8.  Corticosteroids in Myositis and Scleroderma.

Authors:  Anna Postolova; Jennifer K Chen; Lorinda Chung
Journal:  Rheum Dis Clin North Am       Date:  2015-10-26       Impact factor: 2.670

9.  Face and neck swelling in a 16-year-old boy.

Authors:  Erin Peebles; Chitra Pushpanathan; Syed Pirzada; Paul Dancey
Journal:  BMJ Case Rep       Date:  2012-10-06

10.  Screening for the presence of scleroedema adultorum of Buschke in patients with diabetes mellitus: newly diagnosed patients had a high prevalence of dyslipidaemia.

Authors:  Viktória Csonka; Beáta Bódis; Dániel Kovács; Nelli Farkas; Endre Kálmán; László Czirják; Cecília Varjú
Journal:  Lipids Health Dis       Date:  2021-05-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.